Invention Grant
- Patent Title: Bacteria engineered to treat metabolic diseases
-
Application No.: US15738174Application Date: 2016-06-24
-
Publication No.: US11291693B2Publication Date: 2022-04-05
- Inventor: Dean Falb , Vincent M. Isabella , Jonathan W. Kotula , Paul F. Miller , Sarah Rowe , Yves Millet , Adam Fisher
- Applicant: Synlogic Operating Company, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Synlogic Operating Company, Inc.
- Current Assignee: Synlogic Operating Company, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: McCarter & English, LLP
- Agent Marcie B. Clarke
- International Application: PCT/US2016/039444 WO 20160624
- International Announcement: WO2016/210384 WO 20161229
- Main IPC: A61K35/74
- IPC: A61K35/74 ; A23L33/135 ; A61P3/10 ; A61K9/00 ; A61K35/741 ; C12N15/52 ; A61K35/747 ; A61K35/744 ; A61K35/745 ; A61K35/00
Abstract:
Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of attenuating metabolic diseases are disclosed.
Public/Granted literature
- US20190298779A1 BACTERIA ENGINEERED TO TREAT METABOLIC DISEASES Public/Granted day:2019-10-03
Information query
